denkapparat Operations GmbH acquired a new stake in Centene Co. (NYSE:CNC – Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 6,396 shares of the company’s stock, valued at approximately $387,000.
A number of other large investors have also bought and sold shares of CNC. New Age Alpha Advisors LLC acquired a new position in Centene during the 4th quarter worth approximately $5,973,000. Easterly Investment Partners LLC grew its position in Centene by 14.0% in the 4th quarter. Easterly Investment Partners LLC now owns 164,797 shares of the company’s stock valued at $9,983,000 after purchasing an additional 20,252 shares during the period. Norges Bank bought a new stake in Centene during the 4th quarter valued at $1,536,167,000. Caisse Des Depots ET Consignations acquired a new position in shares of Centene during the fourth quarter valued at about $5,998,000. Finally, NEOS Investment Management LLC raised its holdings in shares of Centene by 31.2% in the 4th quarter. NEOS Investment Management LLC now owns 31,378 shares of the company’s stock worth $1,901,000 after acquiring an additional 7,465 shares during the last quarter. 93.63% of the stock is currently owned by institutional investors and hedge funds.
Centene Stock Down 0.5 %
Shares of NYSE:CNC opened at $60.23 on Friday. The company has a market cap of $29.88 billion, a price-to-earnings ratio of 9.65, a PEG ratio of 0.80 and a beta of 0.40. Centene Co. has a one year low of $55.03 and a one year high of $80.59. The firm has a fifty day moving average price of $59.98 and a two-hundred day moving average price of $62.86. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.11 and a quick ratio of 1.10.
Wall Street Analyst Weigh In
A number of analysts have commented on CNC shares. UBS Group raised Centene from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $79.00 to $80.00 in a report on Friday, December 13th. Stephens dropped their price objective on Centene from $75.00 to $73.00 and set an “equal weight” rating on the stock in a research note on Friday, December 13th. Truist Financial lowered their target price on shares of Centene from $89.00 to $84.00 and set a “buy” rating for the company in a report on Friday, December 13th. Jefferies Financial Group downgraded shares of Centene from a “hold” rating to an “underperform” rating and reduced their price objective for the stock from $68.00 to $52.00 in a research report on Tuesday, December 10th. Finally, StockNews.com downgraded Centene from a “strong-buy” rating to a “buy” rating in a research note on Thursday, February 6th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and ten have given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $79.92.
Get Our Latest Analysis on Centene
Centene Profile
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Further Reading
- Five stocks we like better than Centene
- Consumer Staples Stocks, Explained
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- Stock Market Sectors: What Are They and How Many Are There?
- Top 3 Beverage Stocks Pouring Out Profits
- Best Aerospace Stocks Investing
- CarMax and Carvana: Steering the Used Car Market
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.